1. Targeting VEGF with bevacizumab inhibits malignant effusion formation of primary human herpesvirus 8‐unrelated effusion large B‐cell lymphoma in vivo
   Fumiya Ogasawara et al, 2022, Journal of Cellular and Molecular Medicine CrossRef
2. Lymphoproliferative disorder involving body fluid: diagnostic approaches and roles of ancillary studies
   Jiwon Koh et al, 2022, Journal of Pathology and Translational Medicine CrossRef
3. HHV8‐negative primary effusion‐based large B‐cell lymphoma in a patient with chronic myeloid leukemia, BCR::ABL1‐positive under dasatinib treatment: Report of a new case and literature review
   Lucine Christe et al, 2022, Diagnostic Cytopathology CrossRef
4. Classification of B-Cell Lymphomas and Immunodeficiency-Related Lymphoproliferations: What’s New?
   Amy Chadburn et al, 2023, Hemato CrossRef
5. Primary Effusion Lymphoma: A Timely Review on the Association with HIV, HHV8, and EBV
   Chih-Yi Liu et al, 2022, Diagnostics CrossRef
6. Primary Effusion Lymphoma-like Lymphoma Mimicking Tuberculous Pleural Effusion: Three Case Reports and a Literature Review
   Kenta Hayashino et al, 2023, Internal Medicine CrossRef
7. Human herpesvirus 8-negative effusion-based large B-cell lymphoma: a distinct entity with unique clinicopathologic characteristics
   Savanah D. Gisriel et al, 2022, Modern Pathology CrossRef